Skip to main content
Premium Trial:

Request an Annual Quote

MDS Files to Buy Back More Shares

NEW YORK (GenomeWeb News) – MDS said today that it has notified the Toronto Stock Exchange that it may purchase up to roughly 5 percent of the float of its public stock on the TSE and New York Stock Exchange during the next year.

The Toronto-based firm said that during the 12 months commencing July 3, 2008, and ending July 2, 2009, it may purchase up to 4,136,766 MDS common shares on the two exchanges.

As of June 20, MDS said there were around 122 million common shares issued and outstanding and 82.7 million common shares in the public float. MDS said that all shares purchased by the firm under the “normal course issuer bid” will be promptly cancelled. It noted that its daily purchases will be limited to 130,250 common shares, other than block purchase exceptions.

During the past year, MDS purchased and cancelled 1.2 million common shares under a previous normal course issuer bid.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.